clinical trial · NCT07265466
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
Drug Drug Interaction (DDI)JP-1366 and clopidogrelJP-1366 and aspirinJP-1366 and atorvastatinJP-1366 and apixaban
brief summary
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
started
Nov 17, 2025
primary completion
Mar 30, 2026
completion
Mar 30, 2026
last updated
Dec 4, 2025
official title
A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban in Healthy Volunteers.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol